These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 28620495)

  • 1. Familial partial lipodystrophy and proteinuric renal disease due to a missense c.1045C > T
    Fountas A; Giotaki Z; Dounousi E; Liapis G; Bargiota A; Tsatsoulis A; Tigas S
    Endocrinol Diabetes Metab Case Rep; 2017; 2017():. PubMed ID: 28620495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cosegregation of focal segmental glomerulosclerosis in a family with familial partial lipodystrophy due to a mutation in LMNA.
    Thong KM; Xu Y; Cook J; Takou A; Wagner B; Kawar B; Ong AC
    Nephron Clin Pract; 2013; 124(1-2):31-7. PubMed ID: 24080738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic diversity in patients with lipodystrophy associated with LMNA mutations.
    Mory PB; Crispim F; Freire MB; Salles JE; Valério CM; Godoy-Matos AF; Dib SA; Moisés RS
    Eur J Endocrinol; 2012 Sep; 167(3):423-31. PubMed ID: 22700598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multisystem Progeroid Syndrome With Lipodystrophy, Cardiomyopathy, and Nephropathy Due to an
    Hussain I; Jin RR; Baum HBA; Greenfield JR; Devery S; Xing C; Hegele RA; Carranza-Leon BG; Linton MF; Vuitch F; Wu KHC; Precioso DR; Oshima J; Agarwal AK; Garg A
    J Endocr Soc; 2020 Oct; 4(10):bvaa104. PubMed ID: 32939435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipodystrophy: an unusual diagnosis in a case of oligomenorrhea and hirsutism.
    Keller J; Subramanyam L; Simha V; Gustofson R; Minjarez D; Garg A
    Obstet Gynecol; 2009 Aug; 114(2 Pt 2):427-431. PubMed ID: 19622949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical generalized lipoatrophy and severe insulin resistance due to a heterozygous LMNA p.T10I mutation.
    Mory PB; Crispim F; Kasamatsu T; Gabbay MA; Dib SA; Moisés RS
    Arq Bras Endocrinol Metabol; 2008 Nov; 52(8):1252-6. PubMed ID: 19169477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Podocytopathies associated with familial partial lipodystrophy due to LMNA variants: report of two cases.
    Morguetti MJ; Neves PDMM; Korkes I; Padilha WSC; Jorge LB; Watanabe A; Watanabe EH; Malheiros DMAC; Noronha IL; Dib SA; Onuchic LF; Moisés RS
    Arch Endocrinol Metab; 2024 May; 68():e230204. PubMed ID: 38739524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fitting the pieces of the puzzle together: a case report of the Dunnigan-type of familial partial lipodystrophy in the adolescent girl.
    Krawiec P; Mełges B; Pac-Kożuchowska E; Mroczkowska-Juchkiewicz A; Czerska K
    BMC Pediatr; 2016 Mar; 16():38. PubMed ID: 26976018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lamin A/C gene: sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophy.
    Vigouroux C; Magré J; Vantyghem MC; Bourut C; Lascols O; Shackleton S; Lloyd DJ; Guerci B; Padova G; Valensi P; Grimaldi A; Piquemal R; Touraine P; Trembath RC; Capeau J
    Diabetes; 2000 Nov; 49(11):1958-62. PubMed ID: 11078466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of Dunnigan-type familial partial lipodystrophy (FPLD) due to lamin A/C (LMNA) mutations complicated by end-stage renal disease.
    Imachi H; Murao K; Ohtsuka S; Fujiwara M; Muraoka T; Hosokawa H; Ishida T
    Endocrine; 2009 Feb; 35(1):18-21. PubMed ID: 19011997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with familial partial lipodystrophy of the Dunnigan type due to a LMNA R482W mutation show muscular and cardiac abnormalities.
    Vantyghem MC; Pigny P; Maurage CA; Rouaix-Emery N; Stojkovic T; Cuisset JM; Millaire A; Lascols O; Vermersch P; Wemeau JL; Capeau J; Vigouroux C
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5337-46. PubMed ID: 15531479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of an integration-free induced pluripotent stem cell line (PUMCHi001-A) from a patient with familial partial lipodystrophy type 2 (FPLD2) carrying a heterozygous p.R349W (c.1045C > T) mutation in the LMNA gene.
    Xiao C; Yu M; Liu J; Wu H; Deng M; Zhang Q; Xiao X
    Stem Cell Res; 2020 Jan; 42():101651. PubMed ID: 31794942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical presentations, metabolic abnormalities and end-organ complications in patients with familial partial lipodystrophy.
    Akinci B; Onay H; Demir T; Savas-Erdeve Ş; Gen R; Simsir IY; Keskin FE; Erturk MS; Uzum AK; Yaylali GF; Ozdemir NK; Atik T; Ozen S; Yurekli BS; Apaydin T; Altay C; Akinci G; Demir L; Comlekci A; Secil M; Oral EA
    Metabolism; 2017 Jul; 72():109-119. PubMed ID: 28641778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary disease of adipose tissue: When to think about and how to evaluate it in clinical practice?
    Vatier C; Vigouroux C; Mosbah H
    Ann Endocrinol (Paris); 2024 Jun; 85(3):190-194. PubMed ID: 38871502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical Progeroid Syndrome and Partial Lipodystrophy Due to
    Magno S; Ceccarini G; Pelosini C; Ferrari F; Prodam F; Gilio D; Maffei M; Sessa MR; Barison A; Ciccarone A; Emdin M; Aimaretti G; Santini F
    J Endocr Soc; 2020 Oct; 4(10):bvaa108. PubMed ID: 32913962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic heterogeneity in patients with familial partial lipodystrophy (dunnigan variety) related to the site of missense mutations in lamin a/c gene.
    Garg A; Vinaitheerthan M; Weatherall PT; Bowcock AM
    J Clin Endocrinol Metab; 2001 Jan; 86(1):59-65. PubMed ID: 11231979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial partial lipodystrophy associated with the heterozygous LMNA mutation 1445G>A (Arg482Gln) in a Polish family.
    Drac H; Madej-Pilarczyk A; Gospodarczyk-Szot K; Gaweł M; Kwieciński H; Hausmanowa-Petrusewicz I
    Neurol Neurochir Pol; 2010; 44(3):291-6. PubMed ID: 20625965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dyslipemia in familial partial lipodystrophy caused by an R482W mutation in the LMNA gene.
    Schmidt HH; Genschel J; Baier P; Schmidt M; Ockenga J; Tietge UJ; Pröpsting M; Büttner C; Manns MP; Lochs H; Brabant G
    J Clin Endocrinol Metab; 2001 May; 86(5):2289-95. PubMed ID: 11344241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-throughput Second-generation Sequencing Technology Assisted Diagnosis of Familial Partial Lipodystrophy (Type 2 Kobberling-Dunnigan Syndrome): A Case Report.
    Deng M; Chen W; Qi Y
    Comb Chem High Throughput Screen; 2024; 27(2):346-351. PubMed ID: 37231758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dunnigan-type familial partial lipodystrophy associated with the heterozygous R482W mutation in LMNA gene - case study of three women from one family.
    Nabrdalik K; Strózik A; Minkina-Pędras M; Jarosz-Chobot P; Młynarski W; Grzeszczak W; Gumprecht J
    Endokrynol Pol; 2013; 64(4):306-11. PubMed ID: 24002959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.